Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,753.00
Ask: 1,754.00
Change: -19.00 (-1.07%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 03rd Apr 2014 09:05

Associated British Foods: Citi increases target price from 2350p to 3000p, while its neutral rating remains unchanged.Booker Group: Investec shifts target price from 172p to 178p retaining a buy recommendation.BSkyB: HSBC Holdings moves target price from 600p to 610p, while keeping its underweight rating.Burberry: Deutsche Bank cuts target price from 1600p to 1575p maintaining its hold recommendation.CSR: N+1 Singer raises target price to 777p and reiterates its hold recommendation.Daily Mail & General Trust: Jefferies increases target price from 800p to 1016p and maintains a buy recommendation.Direct Line Group: Berenberg ups target price from 230p to 254p and keeps a hold recommendation.easyJet: JP Morgan raises target price from 1725p to 1965p and reiterates an overweight rating.First Group: JP Morgan lowers target price from 165p to 156p and keeps an overweight rating.Glaxo Smith Kline: JP Morgan reduces target price from 1750p to 1700p leaving its neutral rating unchanged.Greene King: JP Morgan lowers target price from 960p to 940p maintaining a neutral rating.Heritage Oil: UBS reduces target price from 325p to 300p, while its buy recommendation is kept.HSBC Holdings: Investec reduces target price from 745p to 640p and downgrades from buy to hold.Hyder Consulting: Investec upgrades from hold to buy with a target price of 510p.Ithaca Energy: Canaccord Genuity lowers target price from 180p to 175p, while its buy recommendation is kept.Lonmin: RBC Capital cuts target price from 370p to 360p and retains an outperform rating.Marston's: JP Morgan reduces target price from 180p to 155p staying with its neutral rating.McBride: Investec places both its target price (prev.: 120p) and its buy recommendation under review. Panmure Gordon cuts target price from 120p to 100p downgrading from buy to hold.Merlin Entertainment: Deutsche Bank raises target price from 395p to 430p and stays with its buy recommendation.Minoan Group: WH Ireland shifts target price from 20p to 28p and stays with its speculative buy recommendation.Mitchells & Butlers: JP Morgan increases target price from 460p to 530p upgrading to overweight.Parkmead Group: Westhouse Securities initiates with a target price of 400p and a buy recommendation.Pennon Group: UBS takes target price from 725p to 795p and reiterates a buy recommendation.Polymetal International: Citi lowers target price from 452p to 450p and stays with its sell recommendation.Resolution: Canaccord Genuity reduces target price from 375p to 300p maintaining a hold recommendation.Restaurant Group: JP Morgan shifts target price from 750p to 755p retaining an overweight rating.Rotork: RBC Capital initiates with a target price of 2800p and a neutral rating.Severn Trent: UBS takes target price from 1825p to 1885p leaving its neutral rating unaltered.Smith & Nephew: Numis downgrades from add to hold with a target price of 1000p.Spirax-Sarco Engineering: RBC Capital initiates with a target price of 3250p and an outperform rating.Tullow Oil: UBS cuts target price from 925p to 900p, while upgrading from neutral to buy.United Utilities: UBS ups target price from 750p to 775p keeping a neutral rating.Wincanton: Investec upgrades from hold to buy with a target price of 155p.
More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.